Search research articles
Contact Us
Filters
Showing results (151-160 of 1,449) with videos related to
Page
of 145
Sort By:
Journal of Chromatography
|
November 29, 1985
Fluorimetric determination of the quaternary compound trospium and its metabolite in biological material after derivatization with benoxaprofen chloride
G Schladitz-Keil, H Spahn, E Mutschler
Fortschritte Der Neurologie-Psychiatrie
|
September 1, 1991
[Clinical effectiveness of zotepine in treatment of negative schizophrenic symptoms. Results of an open and a double-blind controlled trial]
F Müller-Spahn, D Dieterle, M Ackenheil
Der Anaesthesist
|
December 15, 2004
[Glasgow Coma Scale in traumatic brain injury]
C Heim, P Schoettker, D R Spahn
Klinische Monatsblatter Fur Augenheilkunde
|
May 27, 2004
Selective and sequential therapy of oculomotor and palpebral sequelae resulting from biopsy of dorsal midbrain sarcoidosis
G Klainguti, B Spahn, F-X Borruat
Die Pharmazie
|
November 1, 1996
The renin-angiotensin-aldosterone system: focus on its distinct role in arterial hypertension and its various inhibitors as a therapeutic strategy to effectively lower blood pressure
A Soldner, H Spahn-Langguth, E Mutschler
International Clinical Psychopharmacology
|
May 1, 1996
The psychobiology of the acute schizophrenic episode
F Müller-Spahn, P Eich, C Hock
Journal of Pharmaceutical and Biomedical Analysis
|
October 1, 1995
New specific and sensitive HPLC-assays for ethacrynic acid and its main metabolite--the cysteine conjugate--in biological material
B Voith, H Spahn-Langguth, E Mutschler
Annals of the New York Academy of Sciences
|
January 17, 1996
Computer-based cognitive training in Alzheimer's disease patients
M Hofmann, C Hock, F Müller-Spahn
ACS Chemical Neuroscience
|
June 13, 2017
Novel Opioid Analgesics and Side Effects
Giovanna Del Vecchio, Viola Spahn, Christoph Stein
Der Nervenarzt
|
July 1, 1992
[New aspects in the diagnosis, pathogenesis and therapy of schizophrenic negative symptoms]
F Müller-Spahn, S Modell, M Thomma
Page
of 145
Search research articles
Search
Showing results (151-160 of 1,449) with videos related to
Sort By:
Page
of 145
Journal of Chromatography
|
November 29, 1985
Fluorimetric determination of the quaternary compound trospium and its metabolite in biological material after derivatization with benoxaprofen chloride
G Schladitz-Keil, H Spahn, E Mutschler
Fortschritte Der Neurologie-Psychiatrie
|
September 1, 1991
[Clinical effectiveness of zotepine in treatment of negative schizophrenic symptoms. Results of an open and a double-blind controlled trial]
F Müller-Spahn, D Dieterle, M Ackenheil
Der Anaesthesist
|
December 15, 2004
[Glasgow Coma Scale in traumatic brain injury]
C Heim, P Schoettker, D R Spahn
Klinische Monatsblatter Fur Augenheilkunde
|
May 27, 2004
Selective and sequential therapy of oculomotor and palpebral sequelae resulting from biopsy of dorsal midbrain sarcoidosis
G Klainguti, B Spahn, F-X Borruat
Die Pharmazie
|
November 1, 1996
The renin-angiotensin-aldosterone system: focus on its distinct role in arterial hypertension and its various inhibitors as a therapeutic strategy to effectively lower blood pressure
A Soldner, H Spahn-Langguth, E Mutschler
International Clinical Psychopharmacology
|
May 1, 1996
The psychobiology of the acute schizophrenic episode
F Müller-Spahn, P Eich, C Hock
Journal of Pharmaceutical and Biomedical Analysis
|
October 1, 1995
New specific and sensitive HPLC-assays for ethacrynic acid and its main metabolite--the cysteine conjugate--in biological material
B Voith, H Spahn-Langguth, E Mutschler
Annals of the New York Academy of Sciences
|
January 17, 1996
Computer-based cognitive training in Alzheimer's disease patients
M Hofmann, C Hock, F Müller-Spahn
ACS Chemical Neuroscience
|
June 13, 2017
Novel Opioid Analgesics and Side Effects
Giovanna Del Vecchio, Viola Spahn, Christoph Stein
Der Nervenarzt
|
July 1, 1992
[New aspects in the diagnosis, pathogenesis and therapy of schizophrenic negative symptoms]
F Müller-Spahn, S Modell, M Thomma
Page
of 145